AWA
RMD icon

Arkadios Wealth Advisors’s ResMed RMD Stock Holding History

Arkadios Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Buy
1,559
+294
+23% +$73.3K 0.01% 1283
2025
Q4 		$305K Buy
+1,265
New +$324K 0.01% 1248
2020
Q1 		– Sell
-18
Closed -$3.15K – 1278
2019
Q4 		$3.15K Buy
+18
New +$2.59K ﹤0.01% 765

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arkadios Wealth Advisors's RMD Position: Q1 2026 in Review

Arkadios Wealth Advisors increased its ResMed (RMD) stake by 23% in Q1 2026, buying an estimated $73.3K and bringing the position to 1,559 shares worth $350K. The position accounts for 0.01% of the portfolio, ranked #1283.

Arkadios Wealth Advisors first reported a position in RMD in Q4 2019 and has held it in 3 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Arkadios Wealth Advisors held 1,559 shares of ResMed worth $350K as of Q1 2026.
  • Arkadios Wealth Advisors bought 294 ResMed shares in Q1 2026, an estimated $73.3K.
  • ResMed made up 0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #1283 holding.
  • Arkadios Wealth Advisors first reported a position in ResMed in Q4 2019 and has held it in 3 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.